Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Owlstone Medical Ltd.

Latest From Owlstone Medical Ltd.

AstraZeneca Enlists Owlstone Medical To Identify Asthma And COPD Biomarkers

Owlstone Medical has signed another major collaboration agreement with a big pharma company to use its breath biopsy services. The Cambridge, UK company is partnering with AstraZeneca to to identify novel breath biomarkers for asthma and COPD.

Deals Respiratory

Execs On The Move, June 2017

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Leadership BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
    • Diagnostic Equipment & Supplies
  • Research, Analytical Equipment & Supplies
  • Services
  • Therapeutic Areas
  • Cancer
  • Infectious & Viral Diseases
  • Inflammation
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Company Type
  • Start-Up
  • Parent & Subsidiaries
  • Owlstone Medical Ltd.
  • Senior Management
  • Billy Boyle, CEO
    Martin Cartwright, CFO
    David Ruiz-Alonso, COO
    Max Allsworth, CSO
    Chris Hodkinson, VP, Bus. Dev.
  • Contact Info
  • Owlstone Medical Ltd.
    Phone: 1223 428200
    127 Cambridge Science Park
    Milton Rd.
    Cambridge, CB4 0GD